TrialPanorama/TrialPanorama-database huggingface dataset:
Study 8908381 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 8908381 — Predictive Biomarker (PRD): NUCB2 mRNA
Genes: NUCB2; NEFA
Study 31969184 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 16236038 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study 10431944 — Surrogate Endpoint (SUR): Blood pressure
Study 2152233 — Surrogate Endpoint (SUR): Blood pressure
Study 26245756 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 8318561 — Predictive Biomarker (PRD): ABO mRNA
Genes: ABO
Study 28757912 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 28757912 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 24162448 — Surrogate Endpoint (SUR): Serum testosterone
Study 29457221 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 22624993 — Safety Biomarker (SAF): Reactive oxygen species
Study 16841679 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study 10983905 — Safety Biomarker (SAF): Interleukin 1
Study 3855724 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study 16338260 — Surrogate Endpoint (SUR): Blood pressure
Study 7662241 — Surrogate Endpoint (SUR): Blood pressure
Study 15589004 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 29231587 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 25208859 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study 17070426 — Surrogate Endpoint (SUR): Blood pressure
Study 8941101 — Surrogate Endpoint (SUR): Blood pressure
Study 29319935 — Pharmacodynamic Biomarker (PDY): Beta-secretase 1
Genes: BACE1; BACE; KIAA1149
Study 12110497 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 12110497 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 10220012 — Safety Biomarker (SAF): DRD2
Study 26968101 — Surrogate Endpoint (SUR): Serum creatinine
Study 11895146 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 11895146 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 11895146 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 8040669 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 22381427 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 17667193 — Predictive Biomarker (PRD): DMD
Genes: BMD; DXS142; DXS164; DXS206; DXS230; DXS239; DXS268; DXS269; DXS270; DXS272
Study 1253812 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 31533195 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 29042490 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 26252642 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 26252642 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 26252642 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 22071711 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 19893201 — Predictive Biomarker (PRD): GLS2 mRNA
Genes: GLS2; GA
Study 17111195 — Safety Biomarker (SAF): Myeloperoxidase
Genes: MPO
Study 17111195 — Predictive Biomarker (PRD): ROS1
Genes: MCF3; ROS; c-ros-1
Study 17111195 — Predictive Biomarker (PRD): ITGB2 mRNA
Genes: ITGB2; CD18; MFI7
Study 17111195 — Predictive Biomarker (PRD): ADGRE5 mRNA
Genes: ADGRE5; CD97
Study 17111195 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 17111195 — Safety Biomarker (SAF): Reactive oxygen species
Study 15317270 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 15317270 — Safety Biomarker (SAF): IL4
Genes: BSF1; IL-4; BCGF1; BCGF-1; MGC79402
Study 30021580 — Predictive Biomarker (PRD): DCC mRNA
Genes: DCC; IGDCC1
Study 30021580 — Predictive Biomarker (PRD): NNT mRNA
Genes: NNT
Study 10222388 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study 31440235 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 31440235 — Predictive Biomarker (PRD): IRF5 mRNA
Genes: IRF5
Study 31440235 — Predictive Biomarker (PRD): CD27 mRNA
Genes: CD27; TNFRSF7
Study 25902655 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 19675482 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 11304102 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 11304102 — Surrogate Endpoint (SUR): Serum creatinine
Study 29655928 — Surrogate Endpoint (SUR): Blood pressure
Study 11834946 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Platelet glycoprotein 4
Genes: CD36; GP3B; GP4
Study 21211865 — Surrogate Endpoint (SUR): Blood pressure
Study 16083782 — Pharmacodynamic Biomarker (PDY): Cyclic adenosine monophosphate
Study 28027282 — Predictive Biomarker (PRD): S100B mRNA
Genes: S100B
Study 28027282 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 28027282 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 31035775 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 24472799 — Surrogate Endpoint (SUR): Blood pressure
Study 29412045 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 23204156 — Predictive Biomarker (PRD): PON1 mRNA
Genes: PON1; PON
Study 23204156 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 23204156 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 20954968 — Surrogate Endpoint (SUR): Serum bactericidal antibody
Study 18408362 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 12414883 — Predictive Biomarker (PRD): NE
Study 31332099 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 23835365 — Predictive Biomarker (PRD): CXADR mRNA
Genes: CXADR; CAR
Study 18199798 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 18199798 — Safety Biomarker (SAF): ACE
Genes: ACE1; CD143
Study 10745279 — Surrogate Endpoint (SUR): Blood pressure
Study 17174559 — Surrogate Endpoint (SUR): Serum creatinine
Study 12483170 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 9665357 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 7647542 — Predictive Biomarker (PRD): LPO mRNA
Genes: LPO; SAPX
Study 7647542 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 27646937 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 27646937 — Predictive Biomarker (PRD): DAP mRNA
Genes: DAP; DAP1
Study 27941730 — Surrogate Endpoint (SUR): Serum uric acid
Study 19173749 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study 19173749 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 15479125 — Surrogate Endpoint (SUR): Blood pressure
Study 7588920 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 2285255 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 31122901 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 31122901 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 28538025 — Surrogate Endpoint (SUR): Blood pressure
Study 20493642 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 9243350 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study 24199224 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 17022368 — Predictive Biomarker (PRD): RALA mRNA
Genes: RALA; RAL
Study 6124083 — Surrogate Endpoint (SUR): Blood pressure
Study 28617530 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 21292169 — Predictive Biomarker (PRD): PAM mRNA
Genes: PAM
Study 9517598 — Surrogate Endpoint (SUR): Bone mineral density
Study 3050006 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 1545086 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 26944728 — Predictive Biomarker (PRD): LARS1 mRNA
Genes: LARS1; KIAA1352; LARS
Study 15781539 — Surrogate Endpoint (SUR): Forced vital capacity
Study 28203695 — Surrogate Endpoint (SUR): Blood pressure
Study 23683444 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 12761586 — Predictive Biomarker (PRD): DNER mRNA
Genes: DNER; BET; UNQ262/PRO299
Study 7519691 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 7519691 — Surrogate Endpoint (SUR): Blood pressure
Study 7957523 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 7957523 — Predictive Biomarker (PRD): MBP mRNA
Genes: MBP
Study 7957523 — Surrogate Endpoint (SUR): Blood pressure
Study 21545947 — Surrogate Endpoint (SUR): Serum creatinine
Study 19466436 — Pharmacodynamic Biomarker (PDY): Lysosomal acid glucosylceramidase
Genes: GBA1; GBA; GC; GLUC
Study 19466436 — Predictive Biomarker (PRD): SPTLC2 mRNA
Genes: SPTLC2; KIAA0526; LCB2
Study 19466436 — Predictive Biomarker (PRD): SMPD1 mRNA
Genes: SMPD1; ASM
Study 19466436 — Predictive Biomarker (PRD): ALOX12B mRNA
Genes: ALOX12B
Study 19466436 — Predictive Biomarker (PRD): ALOXE3 mRNA
Genes: ALOXE3
Study 19466436 — Predictive Biomarker (PRD): HMGCS1 mRNA
Genes: HMGCS1; HMGCS
Study 19466436 — Predictive Biomarker (PRD): PPARG mRNA
Genes: PPARG; NR1C3
Study 19466436 — Predictive Biomarker (PRD): ACACB mRNA
Genes: ACACB; ACC2; ACCB
Study 19466436 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 31894491 — Surrogate Endpoint (SUR): Bone mineral density
Study 25643895 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 19015590 — Surrogate Endpoint (SUR): Blood pressure
Study 31236143 — Monitoring Biomarker (MOI): Urokinase plasminogen activator surface receptor
Genes: PLAUR; MO3; UPAR
Study 22164810 — Surrogate Endpoint (SUR): Blood pressure
Study 22302034 — Pharmacodynamic Biomarker (PDY): Amyloid beta peptide (1-40)
Genes: APP; A4; AD1
Study 1383592 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 25174283 — Surrogate Endpoint (SUR): Forced vital capacity
Study 22815653 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 16103233 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 16103233 — Surrogate Endpoint (SUR): Blood pressure
Study 16103233 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 16103233 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 11967028 — Surrogate Endpoint (SUR): Blood pressure
Study 21152040 — Pharmacodynamic Biomarker (PDY): Mismatch negativity
Study 24304099 — Predictive Biomarker (PRD): CHAF1A mRNA
Genes: CHAF1A; CAF; CAF1P150
Study 17981316 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 9665010 — Surrogate Endpoint (SUR): Serum creatinine
Study 8297546 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 20098455 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 18003764 — Surrogate Endpoint (SUR): Serum creatinine
Study 15182393 — Predictive Biomarker (PRD): NAT8 mRNA
Genes: NAT8; CML1; GLA; TSC501
Study 22828553 — Surrogate Endpoint (SUR): Serum creatinine
Study 20819493 — Predictive Biomarker (PRD): NDP mRNA
Genes: NDP; EVR2
Study 2782734 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 31169883 — Safety Biomarker (SAF): CYP11B1 mRNA
Genes: CYP11B1; S11BH
Study 31169883 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CYP17A1 mRNA
Genes: CYP17A1; CYP17; S17AH
Study 31169883 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study 31169883 — Predictive Biomarker (PRD): HSD17B12 mRNA
Genes: HSD17B12; SDR12C1
Study 31169883 — Predictive Biomarker (PRD): WNT4 mRNA
Genes: WNT4; UNQ426/PRO864
Study 23139262 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 18438705 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 18438705 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 14679377 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 14679377 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 3285829 — Safety Biomarker (SAF): 51Cr-EDTA
Study 9382659 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 8322563 — Surrogate Endpoint (SUR): Blood pressure
Study 2868656 — Surrogate Endpoint (SUR): Blood pressure
Study 2868656 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 23301475 — Predictive Biomarker (PRD): PBX1 mRNA
Genes: PBX1; PRL
Study 20506356 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 12621135 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study 12621135 — Surrogate Endpoint (SUR): Bone mineral density
Study 26647926 — Surrogate Endpoint (SUR): Probing pocket depth
Study 15484172 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 15484172 — Surrogate Endpoint (SUR): Blood pressure
Study 8996166 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study 8996166 — Safety Biomarker (SAF): Dihydrothymine dehydrogenase
Genes: DPYD
Study 29053933 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 29053933 — Safety Biomarker (SAF): BDNF
Study 29053933 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 15699766 — Surrogate Endpoint (SUR): Serum creatinine
Study 6354932 — Surrogate Endpoint (SUR): Blood pressure
Study 20830534 — Surrogate Endpoint (SUR): Plasma ammonia
Study 12469360 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study 2594822 — Surrogate Endpoint (SUR): Forced vital capacity
Study 17462541 — Surrogate Endpoint (SUR): Blood pressure
Study 16496609 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 16496609 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 16496609 — Safety Biomarker (SAF): ACE
Genes: ACE1; CD143
Study 16496609 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 2183868 — Surrogate Endpoint (SUR): Blood pressure
Study 26044442 — Surrogate Endpoint (SUR): Blood pressure
Study 7011964 — Surrogate Endpoint (SUR): Blood pressure
Study 16222404 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 7589028 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study 28202004 — Predictive Biomarker (PRD): CHEK1 mRNA
Genes: CHEK1; CHK1
Study 15252191 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 15252191 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 10758467 — Surrogate Endpoint (SUR): Blood pressure
Study 8649652 — Safety Biomarker (SAF): 51Cr-EDTA
Study 6731015 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 31081924 — Predictive Biomarker (PRD): F10 mRNA
Genes: F10
Study 28462519 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 23801842 — Monitoring Biomarker (MOI): HBV DNA
Study 12180581 — Surrogate Endpoint (SUR): Blood pressure
Study 7741773 — Surrogate Endpoint (SUR): Blood pressure
Study 1970370 — Surrogate Endpoint (SUR): Serum creatinine
Study 1970370 — Surrogate Endpoint (SUR): Blood pressure
Study 30256671 — Surrogate Endpoint (SUR): Blood pressure
Study 24472614 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study 18087004 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 11585312 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study 31856576 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study 31856576 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study 31856576 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 22051427 — Surrogate Endpoint (SUR): Blood pressure
Study 31311721 — Safety Biomarker (SAF): Type I cytoskeletal 18 Keratin
Genes: KRT18; CYK18; PIG46
Study 31311721 — Safety Biomarker (SAF): Glutamate dehydrogenase
Study 28003211 — Surrogate Endpoint (SUR): Blood pressure
Study 24217302 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 7781842 — Surrogate Endpoint (SUR): Blood pressure
Study 2355104 — Surrogate Endpoint (SUR): Blood pressure
Study 343414 — Surrogate Endpoint (SUR): Blood pressure
Study 24879050 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 20060945 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 20060945 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 20060945 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study 30905872 — Surrogate Endpoint (SUR): Blood pressure
Study 28445286 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 28445286 — Predictive Biomarker (PRD): S100B mRNA
Genes: S100B
Study 15200450 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study 15200450 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 15200450 — Safety Biomarker (SAF): Hyaluronic acid
Study 15200450 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 15200450 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 12074777 — Predictive Biomarker (PRD): SCN8A mRNA
Genes: SCN8A; MED
Study 6342395 — Surrogate Endpoint (SUR): Serum calcium
Study 30193081 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 26520703 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 29990565 — Surrogate Endpoint (SUR): Blood pressure
Study 24762066 — Predictive Biomarker (PRD): ALDH1A1 mRNA
Genes: ALDH1A1; ALDC; ALDH1; PUMB1
Study 24762066 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 20205108 — Predictive Biomarker (PRD); Safety Biomarker (SAF): SLC2A4 mRNA
Genes: SLC2A4; GLUT4
Study 12185327 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 7793648 — Surrogate Endpoint (SUR): Blood pressure
Study 1684743 — Surrogate Endpoint (SUR): Blood pressure
Study 20063407 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 11302283 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 11302283 — Surrogate Endpoint (SUR): Blood pressure
Study 29875020 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 17228674 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Matrix metalloproteinase 3
Genes: MMP3; STMY1
Study 17228674 — Safety Biomarker (SAF): Interleukin 1
Study 14623654 — Surrogate Endpoint (SUR): Bone mineral density
Study 7299342 — Surrogate Endpoint (SUR): Blood pressure
Study 28818518 — Safety Biomarker (SAF): Peroxisome proliferator-activated receptor delta
Genes: PPARD
Study 2680964 — Surrogate Endpoint (SUR): Blood pressure
Study 15302980 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 15302980 — Surrogate Endpoint (SUR): Blood pressure
Study 11149479 — Surrogate Endpoint (SUR): Bone mineral density
Study 25659070 — Predictive Biomarker (PRD): TKTL1 mRNA
Genes: TKTL1; TKR; TKT2
Study 19952825 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 19952825 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 18823310 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 12631257 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 12631257 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 12631257 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study 10994765 — Surrogate Endpoint (SUR): Blood pressure
Study 29626068 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study 29626068 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 27086024 — Pharmacodynamic Biomarker (PDY): Human leukocyte antigen DR
Study 27086024 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study 15968765 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 24531203 — Surrogate Endpoint (SUR): Blood pressure
Study 23067923 — Surrogate Endpoint (SUR): Blood pressure
Study 18981463 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study 28271312 — Safety Biomarker (SAF): Myeloperoxidase
Genes: MPO
Study 25935433 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 25935433 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 2528705 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 12917503 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 12917503 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 9013263 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 29759061 — Predictive Biomarker (PRD): NXF1 mRNA
Genes: NXF1; TAP
Study 24708394 — Predictive Biomarker (PRD); Safety Biomarker (SAF): FGG mRNA
Genes: FGG; PRO2061
Study 22230323 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 22230323 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 22230323 — Predictive Biomarker (PRD): PTPN2 mRNA
Genes: PTPN2; PTPT
Study 20723849 — Predictive Biomarker (PRD): GPI mRNA
Genes: GPI
Study 14675884 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 14675884 — Surrogate Endpoint (SUR): Blood pressure
Study 8971373 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 30322875 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 19531640 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 2455155 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 2455155 — Surrogate Endpoint (SUR): Blood pressure
Study 31628477 — Predictive Biomarker (PRD); Safety Biomarker (SAF): SLC2A4 mRNA
Genes: SLC2A4; GLUT4